The Pharmacist Write Resources Hub
Categories
Categories
All
Managed Care Pharmacy
(33)
GLP1 Hub
(26)
Technology and AI in Pharmacy
(25)
Patient Education and Medication Management
(22)
Essays
(17)
Opinion
(9)
Healthcare Navigation and Insurance Literacy
(5)
Trading
(3)
Aisembly
(2)
Future of Pharmacy
(2)
Biotech or Brick Series
(1)
P3S
(1)
Long-Chain Contextual Reframing: Restoring Meaning Through Context
Essays
Andrew Vargas, PharmD
November 30, 2025
3:55 pm
No Comments
The Employer’s Guide to PBMs & Drug Coverage
Managed Care Pharmacy
Andrew Vargas, PharmD
November 26, 2025
8:21 pm
No Comments
It’s Agentic: Boogie Woogie Woogie
Future of Pharmacy
Andrew Vargas, PharmD
November 24, 2025
6:15 pm
No Comments
Beyond the PDF: Why We Need a “Compositional Grammar” for Coverage Rules
Managed Care Pharmacy
Andrew Vargas, PharmD
November 11, 2025
4:23 pm
No Comments
The 90% Problem: Why GenAI Alone Can’t Solve Prior Authorization
Managed Care Pharmacy
Andrew Vargas, PharmD
November 7, 2025
5:32 pm
No Comments
Policy Vault: from PDFs and Portals to FHIR‑Ready Coverage Rules
Managed Care Pharmacy
Andrew Vargas, PharmD
November 3, 2025
7:14 pm
No Comments
GLP‑1 Coverage & Prior Authorization Checklist (Full 2025 Guide)
GLP1 Hub
Andrew Vargas, PharmD
October 9, 2025
4:47 pm
No Comments
Part 9: Bonus — Underwriting Transparent Drug Coverage
Essays
Andrew Vargas, PharmD
October 8, 2025
4:27 pm
No Comments
Part 8: The Fall of Rebates and the Rise of NodeID — Toward Transparent, Fixed-Gain Drug Access
Essays
Andrew Vargas, PharmD
October 7, 2025
6:16 pm
No Comments
Sunset Strategy: How Amgen’s Repatha Shows the Future of Late-Stage Asset Pharma Pricing
Managed Care Pharmacy
Andrew Vargas, PharmD
October 7, 2025
3:19 pm
No Comments
On Attention
Aisembly
Andrew Vargas, PharmD
October 1, 2025
4:29 pm
No Comments
Strensiq: An End‑to‑End FWA Risk Scenario
Managed Care Pharmacy
Andrew Vargas, PharmD
September 26, 2025
9:28 pm
No Comments
How Pharmacy Payers Change Policy: A Process Overview
Managed Care Pharmacy
Andrew Vargas, PharmD
September 26, 2025
3:41 pm
No Comments
ACC/AHA’s 2025 Guideline Playbook: How to Build Care—and Tools—That Earn Trust
Essays
Andrew Vargas, PharmD
September 26, 2025
2:23 pm
No Comments
On Exploitation
Aisembly
Andrew Vargas, PharmD
September 25, 2025
2:45 pm
No Comments
From Chaos to Counsel: A Framework for Facilitative Promotion
Essays
Andrew Vargas
September 23, 2025
1:50 pm
No Comments
Alternative Careers for Pharmacists: Expand Your Path
Future of Pharmacy
Andrew Vargas, PharmD
September 8, 2025
6:58 pm
No Comments
Covered Calls: Building Your First Income Stream
Trading
Andrew Vargas
September 5, 2025
8:43 pm
No Comments
What a Simple Drug Prior Authorization Policy Looks Like
Managed Care Pharmacy
Andrew Vargas, PharmD
June 22, 2025
5:15 pm
No Comments
From Extraction to Circulation: The Future of Billing Is Cooperative
Essays
Andrew Vargas
June 4, 2025
7:11 pm
No Comments
Fear Is Not the Foe: Notes on Perceptual Pressure and the Soft Science of Sovereignty
Essays
Andrew Vargas
June 4, 2025
1:23 am
No Comments
The Platform Is the Train: How Algorithmic Anesthesia Is Rewiring Our Will
Essays
Andrew Vargas
May 31, 2025
8:14 pm
No Comments
The Goodness Arbitrage Protocol (GAP): An Ethical Framework for Reflective Creation
Essays
Andrew Vargas
May 26, 2025
2:07 am
No Comments
Reflective Intelligence 101: How to Move from Resonance to Compellence with Calm, Clarity, and Conviction
Essays
Andrew Vargas
May 26, 2025
12:47 am
No Comments
Designing a Value-Based Formulary in 10 Steps
Managed Care Pharmacy
Andrew Vargas, PharmD
May 22, 2025
11:24 am
No Comments
Switching from Semaglutide to Tirzepatide Dose Conversion Best Practices
GLP1 Hub
Andrew Vargas, PharmD
May 20, 2025
3:05 am
No Comments
How Long Can You Stay on Semaglutide for Weight Loss
GLP1 Hub
Andrew Vargas, PharmD
May 20, 2025
3:05 am
No Comments
Zepbound vs Semaglutide Safety Efficacy Coverage
GLP1 Hub
Andrew Vargas, PharmD
May 20, 2025
3:05 am
No Comments
Zepbound vs Mounjaro Which Is Better for Weight Loss
GLP1 Hub
Andrew Vargas, PharmD
May 20, 2025
3:05 am
No Comments
Is Zepbound the Same as Tirzepatide Understanding Brands and Generics
GLP1 Hub
Andrew Vargas, PharmD
May 20, 2025
3:05 am
No Comments
Zepbound vs Ozempic Key Differences for Weight Loss
GLP1 Hub
Andrew Vargas, PharmD
May 20, 2025
3:05 am
No Comments
How I Produced 100+ SEO/AIO-Optimized Articles Combining AI and Pharmacy Expertise
Technology and AI in Pharmacy
Andrew Vargas, PharmD
May 16, 2025
5:46 pm
No Comments
The P3S Framework: A Virtuous Cycle for Career Growth and Reflective Leadership
P3S
Andrew Vargas
May 14, 2025
6:16 pm
No Comments
Pharmacy Benefit Management Consulting: What You Need to Know
Managed Care Pharmacy
Andrew Vargas, PharmD
April 12, 2025
5:51 pm
No Comments
Wegovy 1 Month Results: Setting Realistic Expectations
GLP1 Hub
Andrew Vargas, PharmD
April 7, 2025
2:27 pm
No Comments
Does Wegovy Give You Energy? Separating Fact from Fiction
GLP1 Hub
Andrew Vargas, PharmD
April 7, 2025
1:36 pm
No Comments
Knockout Gene-Inspired Prior Authorization Logic
Managed Care Pharmacy
Andrew Vargas, PharmD
March 18, 2025
1:26 am
No Comments
How Pharmacy Benefit Analytics Improves Plan Efficiency & Cost Management
Managed Care Pharmacy
Andrew Vargas, PharmD
February 11, 2025
3:56 pm
No Comments
Tackling Wegovy Fatigue: Why It Happens & How to Cope
Patient Education and Medication Management
Andrew Vargas, PharmD
February 11, 2025
3:31 pm
No Comments
Drug Utilization Management 101: Rules, Tools & Best Practices
Managed Care Pharmacy
Andrew Vargas, PharmD
February 10, 2025
1:23 am
No Comments
Unedited & Unfiltered: An Experience with Zepbound on a Weight Loss Journey
Patient Education and Medication Management
Andrew Vargas, PharmD
February 7, 2025
7:26 pm
No Comments
Wegovy Maintenance Dose After Goal Weight: What Patients Need to Know
Patient Education and Medication Management
Andrew Vargas, PharmD
February 5, 2025
2:00 am
No Comments
At What Dose Does Wegovy Start Working? A Pharmacist’s Perspective
Patient Education and Medication Management
Andrew Vargas, PharmD
February 5, 2025
1:02 am
No Comments
Semaglutide vs. Tirzepatide: Mechanisms, Differences, & Outcomes
GLP1 Hub
Andrew Vargas, PharmD
February 4, 2025
1:06 am
No Comments
Understanding GLP 1 & GLP1/GIP: The Superior Drug Class in Weight Management
Patient Education and Medication Management
Andrew Vargas, PharmD
February 4, 2025
12:48 am
No Comments
Part 7: Gradual Governance Transfer – Shifting from Centralized PBMs to a Distributed, Multi-Stakeholder Model
Essays
Andrew Vargas, PharmD
January 7, 2025
9:52 pm
No Comments
Part 6: Applying Elinor Ostrom’s Framework – How Institutional Diversity Shapes Drug Coverage Node Enumeration
Essays
Andrew Vargas, PharmD
January 4, 2025
5:24 am
No Comments
Part 5: Drug-Coverage Node Enumeration: Real-World Applications, Pilot Opportunities, and Future Outlook
Essays
Andrew Vargas, PharmD
January 3, 2025
4:46 pm
No Comments
Part 4: Building an Open Infrastructure for Node-Based Drug Coverage
Essays
Andrew Vargas, PharmD
January 3, 2025
3:53 am
One Comment
Part 3: Building the Exhaustive Parameter Library: Enumerating All Coverage Options
Essays
Andrew Vargas, PharmD
January 3, 2025
1:41 am
No Comments